AstraZeneca plc (ADR) (AZN): Do Major Drug Manufacturers Have Room to Grow?
Major drug manufacturers are literally a market sector unto themselves.
Posts Tagged ‘NYSE:LLY’
Zoetis Inc (ZTS), Pfizer Inc. (PFE): What About The Competition?
Dividend stocks are everywhere, but many just downright stink. In some cases, the business model is in serious jeopardy, or the dividend itself isn't sustainable.
MannKind Corporation (MNKD): Why Have Shares Moved?
MannKind Corporation (NASDAQ:MNKD) took one giant leap over the past few days.
Baxter International Inc. (BAX), Eli Lilly & Co. (LLY): Diagnosing Alzheimer’s First
Alzheimer's is a debilitating neurodegenerative disorder affecting approximately 5 million Americans, yet its causes are remarkably enigmatic. Nonetheless, pharma and biotech...
And The Best Bargain Is…Bristol Myers Squibb Co. (BMY), Eli Lilly & Co. (LLY) or Pfizer Inc. (PFE)?
Many stocks within the pharmaceutical industry have rallied significantly over the past few years and now sit at multi-year highs.
PDL BioPharma Inc. (PDLI), AbbVie Inc (ABBV): Two Scariest Dividend Stocks in Health Care
Combining nice dividends with a growing industry that comprises roughly one-fifth of the nation's GDP should make for an attractive stock -- in theory.
Eli Lilly & Co. (LLY), Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): These Stocks Are Still Solid Long-Term Picks
Confirmation bias – one of the psychological traps investors can be most prone to falling victim to.
GlaxoSmithKline plc (ADR) (GSK), Eli Lilly & Co. (LLY): This Week in Biotech
With the SPDR S&P Biotech Index up 32% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Merck & Co., Inc. (MRK): Big Payout, Little Flexibility
Big pharma isn't the first industry many investors envision when dreaming of the big profits to be made from health care stocks.
MannKind Corporation (MNKD): Should You Buy?
Perennial underdog MannKind Corporation (NASDAQ:MNKD) could be on its countdown to liftoff.
Bristol Myers Squibb Co. (NBMY), Eli Lilly & Co. (LLY), Johnson & Johnson (JNJ): Six Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part I
The healthcare sector has been known for paying dependable dividends and producing strong total returns over time.
Eli Lilly & Co. (LLY), GlaxoSmithKline plc (ADR) (GSK), And Why You Don’t Have to Run a Cartel to Make Big Profits in Drugs
The market for prescription and over-the-counter drugs is huge and hugely profitable.
Bristol Myers Squibb Co. (BMY), And Talk Of Dividend Yields In Pharma
As the market continues to climb, investors are beginning to see thinning dividend yields on many of their big pharma shares.
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY) & Other Names To Know: A Full Breakdown
Investing in biotech companies can be intimidating, especially for investors without a science background. But there's hope.
Auxilium Pharmaceuticals, Inc. (AUXL), AbbVie Inc (ABBV), Eli Lilly & Co. (LLY): Is The Risk Worth The Large Potential Reward?
Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) stock has a lot of negative sentiment priced into the shares, maybe too much at this point.
Merck & Co., Inc. (MRK): Will Dividends Keep Going Strong?
Throughout the years, some of the best performing pharmaceutical industry stocks have had long histories of providing healthy dividends to their stockholders. Merck & Co., Inc...
Abbott Laboratories (ABT), Eli Lilly & Co. (LLY) And Why Diabetes Isn’t Good for Health, But It Can Be for Your Portfolio
When I was six years old, something happened to me that I have never forgotten and will probably always live with.
Apple Inc. (AAPL), Novo Nordisk A/S (ADR) (NVO) & ‘The Most Sustainable Company in the World’
In January of 2012, Business Magazine released a list of the most sustainable companies in the world. You might be surprised to see who topped their list.
Eli Lilly & Co. (LLY): The Company Beats on Earnings Per Share
Eli Lilly & Co. (NYSE:LLY) notched revenue of $5.60 billion. The 12 analysts polled by S&P Capital IQ expected to see a top line of $5.68 billion on the same basis.
Merck & Co., Inc. (MRK): One Potential Roadblock For A Stock Runup
If you own Merck & Co., Inc. (NYSE:MRK) stock, you likely enjoyed the past couple of months.
Eli Lilly & Co. (LLY): Will The Big Bets Pay Off?
Tomorrow, Eli Lilly & Co. (NYSE:LLY) will release its latest quarterly results.
Eli Lilly & Co. (LLY), WellPoint, Inc. (WLP) & Five Must-Watch Earnings Reports in the Health-Care Sector This Week
If you haven't noticed, it's earnings season once again! Believe it or not, there are times when earnings reports slow down in frequency, but this is certainly not one of those...
Vertex Pharmaceuticals Incorporated (VRTX), Gilead Sciences, Inc. (GILD): The Week, Biotech – Part Two
As I mentioned previously in Part 1, it was an incredibly busy week for the biotech sector.
Alkermes Plc (ALKS), Pfizer Inc. (PFE), Eli Lilly & Co. (LLY): These Biotech Investors Are Far From Depressed
The drug produced a statistically significant improvement in three different rating scales for depression compared to placebo.
Merck & Co., Inc. (MRK)’s Latest Drug and Strategy Concoctions
Merck & Co., Inc. (NYSE:MRK) reported a 7% decline in fourth-quarter profit after the patent expiry of Singulair on August 13, 2012, in the United States.
ACADIA Pharmaceuticals Inc. (ACAD): FDA Throws This Stock a Juicy Bone
I had recommended staying away from the company for now because it looked too risky with a long wait before the company could complete its second phase 3 trial for pimavanserin...
Bristol Myers Squibb Co. (BMY): Is This Company Destined for Greatness?
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
AstraZeneca plc (ADR) (AZN): Hedge Funds are Bearish…What to Do?
Is AstraZeneca plc (ADR) (NYSE:AZN) worth your attention right now? The smart money is becoming less confident. The number of long hedge fund bets fell by 2 lately.
Eli Lilly & Co. (LLY), Merck & Co., Inc. (MRK): Three Ways Big Pharma Is Seizing This Rare Opportunity
Making money in business typically happens in one of two ways. You either sell a relatively low-cost product to a large number of customers.
Bristol Myers Squibb Co. (BMY), Eli Lilly & Co. (LLY): This Pharma’s Dividend Is Safe for Now
Recently, with the loss of patents causing generic competition, the main attraction to pharmaceutical companies has been their dividend.
Abbott Laboratories (ABT), Eli Lilly & Co. (LLY), Regeneron Pharmaceuticals Inc (REGN): Is Johnson & Johnson (JNJ) a Cash King?
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Eli Lilly & Co. (NYSE:LLY): Insiders Are Dumping, Should You?
To most shareholders, hedge funds are seen as slow, outdated investment vehicles of the past.
Pfizer Inc. (PFE), Johnson & Johnson (JNJ): Is Obamacare a Disaster Waiting to Happen for Big Pharma?
Big pharma loves Obamacare, right? After all, the main lobbying group for big pharma, the Pharmaceutical Researchers and Manufacturers of America, or PhRMA, spent $150 million...
SUPERVALU INC. (SVU), AstraZeneca plc (ADR) (AZN): Whoa! What Just Happened to My Stock?
The EU's decision to seize the bank accounts of ordinary Cypriot depositors was front and center again as concerns that the financial sector could come under tremendous pressure...
Orphan Drug Is Headed Back to Its Parent: NPS Pharmaceuticals, Inc. (NPSP), Eli Lilly & Co. (LLY)
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is bringing its kids home.
Is Bigger Better When it Comes to Big Pharma? Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Eli Lilly & Co. (LLY)
The demand for drugs worldwide is expected to increase due to emerging markets abroad and more specifically, due to an influx of demand from the aging "Baby Boomers" domestically...
Bristol Myers Squibb Co. (BMY), Eli Lilly & Co. (LLY): 3 Big Concerns for the Pharmaceutical Industry
It's not uncommon for me to applaud the pharmaceutical industry as a solid long-term investment.
There Is Big Money in Drugs.. Legal Ones! – Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Eli Lilly & Co. (LLY)
One thing that many investors become fixated on is always wanting the next 'hot tip' or the 'inside word.' Forever seeking an edge on everyone else, investors seek the holy grail...
Does Eli Lilly & Co. (LLY)’s Dividend Have Room to Soar?
With interest rates still sitting near record lows, investors looking for current income have been forced to move from fixed-income positions and into stocks to find yield.
Why Buffett Is Just Saying No to These Drug Majors: Bristol Myers Squibb Co. (BMY), Eli Lilly & Co. (LLY), AstraZeneca plc (ADR) (AZN)
Global pharmaceutical giants AstraZeneca plc (ADR) (NYSE:AZN), Bristol Myers Squibb Co. (NYSE:BMY), and Eli Lilly & Co. (NYSE:LLY) meet most of the growth and profitability...
$28 Billion Hedge Fund Winton Capital’s Top Stock Picks for 2013: Consolidated Edison, Inc. (ED), Verizon Communications Inc. (VZ), Eli Lilly & Co. (LLY)
Winton Capital was founded by David Harding in 1997. Primarily a quantitative fund, it had over $25 billion in assets under management roughly a year ago.
Down 12%: Navidea Biopharmaceuticals Inc. (NAVB)’s Post-Approval Plunge – Eli Lilly & Co. (LLY), Cardinal Health, Inc. (CAH)
The company got a mid-day Food and Drug Administration approval for its lymph node diagnostic Lymphoseek.
Will Testosterone Fuel Biotech’s Next Great Race? – AbbVie Inc (ABBV), Eli Lilly & Co. (LLY)
Boys will be boys. We fight, we apologize, and we enjoy some cold ones the next day like nothing happened.
CAPScall of the Week: Clovis Oncology Inc (CLVS)
For years, satirical late-night TV host Stephen Colbert has been running a series on his show called "Better Know a District," which highlights one of the 435 U.S.
Is This Great Stock Trading for a Great Price? – Johnson & Johnson (JNJ), Pfizer Inc. (PFE), Eli Lilly & Co. (LLY)
One of my favorite Warren Buffett quotes is that it’s far better to buy a wonderful company trading at a fair price than a fair company trading at a wonderful price. While...
Which Pharmaceutical Stock Should You Invest In? – Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Eli Lilly & Co. (LLY)
A common trap many investors fall into is becoming overly confident in their views. This leads to wagering too much on a single outcome.
Pharmaceutical Winners And Losers In Early 2013: Johnson & Johnson (JNJ), Sanofi SA (ADR) (SNY), Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
Ultimately, that was the loss of those optimists. As value investors, we are not afraid of bad news as long as we get compensated by low valuations.
Will Eli Lilly & Co. (LLY) Help You Retire Rich? – GlaxoSmithKline plc (ADR) (GSK), Johnson & Johnson (JNJ)
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
